Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo(4,5-b)pyridin-2-yl)pyridin-2-amine
2. Arq 092
1. 1313881-70-7
2. Arq-092
3. Akt Inhibitor 2
4. Arq 092 Free Base
5. Arq 092
6. Miransertib [inn]
7. Arq092
8. Miransertib [usan]
9. Miransertib [who-dd]
10. T1dqi1b52y
11. 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
12. 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
13. 3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
14. 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo(4,5-b)pyridin-2-yl)-2-pyridinamine
15. 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo(4,5-b)pyridin-2-yl)pyridin-2-amine
16. 2-pyridinamine, 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo(4,5-b)pyridin-2-yl)-
17. Miransertib (usan/inn)
18. Miransertib [usan:inn]
19. Miransertib (arq-092)
20. Unii-t1dqi1b52y
21. Gtpl9429
22. Schembl2187875
23. Arq 092 [who-dd]
24. Chembl4297188
25. Bcp19821
26. Ex-a1268
27. Nsc791328
28. Who 10490
29. Zinc72315647
30. Cs-5377
31. Db14982
32. Nsc-791328
33. Sb19688
34. Compound 21a [pmid: 27305487]
35. Ac-35486
36. Hy-19719
37. Db-105304
38. S6811
39. J3.532.768a
40. D11409
41. A922251
42. Q27456535
43. 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3himidazo(4,5-b)pyridin-2-yl)pyridin-2-amine
44. 6s1
| Molecular Weight | 432.5 g/mol |
|---|---|
| Molecular Formula | C27H24N6 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 432.20624479 g/mol |
| Monoisotopic Mass | 432.20624479 g/mol |
| Topological Polar Surface Area | 95.6 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 653 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
29
PharmaCompass offers a list of Miransertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Miransertib manufacturer or Miransertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Miransertib manufacturer or Miransertib supplier.
PharmaCompass also assists you with knowing the Miransertib API Price utilized in the formulation of products. Miransertib API Price is not always fixed or binding as the Miransertib Price is obtained through a variety of data sources. The Miransertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Miransertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Miransertib, including repackagers and relabelers. The FDA regulates Miransertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Miransertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Miransertib supplier is an individual or a company that provides Miransertib active pharmaceutical ingredient (API) or Miransertib finished formulations upon request. The Miransertib suppliers may include Miransertib API manufacturers, exporters, distributors and traders.
Miransertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Miransertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Miransertib GMP manufacturer or Miransertib GMP API supplier for your needs.
A Miransertib CoA (Certificate of Analysis) is a formal document that attests to Miransertib's compliance with Miransertib specifications and serves as a tool for batch-level quality control.
Miransertib CoA mostly includes findings from lab analyses of a specific batch. For each Miransertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Miransertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Miransertib EP), Miransertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Miransertib USP).
